Edelweiss Large Cap Fund
The scheme seeks to provide capital appreciation from a portfolio that is predominantly consisting equity and equity related securities of the 100 largest corporates by market capitalization listed in India.
Growthvine rating: 4/5 — ranked #10 of 41 in category.
Fund basics
| Category | Equity: Large Cap |
|---|
| NAV | ₹82.26 (as of 2026-09-11) |
|---|
| AUM | ₹1,434 Cr |
|---|
| Expense ratio | 1.82% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Bharat Lahoti |
|---|
| Exit load | 1% for redemption within 90 days |
|---|
Performance & risk
| 5-year annualised return | 9.20% |
|---|
| Sharpe ratio | 0.32 |
|---|
| Standard deviation | 13.94% |
|---|
| Max drawdown | -35.26% |
|---|
| Alpha | -0.38 |
|---|
| Beta | 0.96 |
|---|
Over 5 years, captured 96.8% of NIFTY 100's upside and 92.2% of its downside.
Market cap allocation
| Large cap | 83.9% |
|---|
| Mid cap | 13.1% |
|---|
| Small cap | 3.0% |
|---|
Concentration
| Top 5 holdings | 28.4% |
|---|
| Top 10 holdings | 42.9% |
|---|
| Total holdings | 72 |
|---|
| Index overlap | 66.7% |
|---|
| Active share | 33.3% |
|---|
Top holdings
- ICICI Bank Ltd. — 7.7%
- HDFC Bank Ltd. — 6.9%
- Reliance Industries Ltd — 5.6%
- Larsen & Toubro Limited — 4.4%
- Bharti Airtel Ltd. — 3.9%
- Bajaj Finance Limited — 3.0%
- Sun Pharmaceutical Industries Ltd. — 3.0%
- State Bank Of India — 2.8%
- Titan Company Limited — 2.8%
- Mahindra & Mahindra Ltd. — 2.8%
Top sectors
- Banking & Financial — 23.0%
- Pharma & Biotech — 9.7%
- Automobile — 8.9%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | -5.5% | Q2 | #20 of 39 |
| 2025 | 7.2% | Q3 | #22 of 36 |
| 2024 | 14.6% | Q2 | #16 of 32 |
| 2023 | 25.7% | Q2 | #11 of 32 |
| 2022 | 3.4% | Q2 | #11 of 28 |